Grant: ARIA TA3: Transforming Clinical Trial Design Using Safe AI (Advanced Research and Invention Agency (ARIA) → University of Oxford)
The record claims the grantee is 'University of Oxford,' but the source clearly identifies Lindus Health as the primary grant recipient ('ARIA has granted funds to anti-clinical research organisation (CRO) Lindus Health'). While the University of Oxford is mentioned as a collaborating partner through Nobuko Yoshida's research group, it is not the grantee. The source also does not mention 'ARIA TA3' as the grant name—it refers to the project as part of 'ARIA's Safeguarded AI programme' and names it 'Transforming clinical trial design using safe and reliable AI.' The grantee field is fundamentally incorrect.
Our claim
entire recordNo record data available.
Source evidence
1 src · 1 checkNoteThe record claims the grantee is 'University of Oxford,' but the source clearly identifies Lindus Health as the primary grant recipient ('ARIA has granted funds to anti-clinical research organisation (CRO) Lindus Health'). While the University of Oxford is mentioned as a collaborating partner through Nobuko Yoshida's research group, it is not the grantee. The source also does not mention 'ARIA TA3' as the grant name—it refers to the project as part of 'ARIA's Safeguarded AI programme' and names it 'Transforming clinical trial design using safe and reliable AI.' The grantee field is fundamentally incorrect.